Mega Lifesciences

MEGA

TH4984010009

Pharmaceuticals

End-of-day quote Thailand S.E. Other stock markets 06:00:00 2024-05-20 pm EDT			5-day change	1st Jan Change
40.25 ^THB	-1.23%		-0.62%	0.00%

May. 13	Mega Lifesciences Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Feb. 23	Transcript : Mega Lifesciences Public Company Limited, 2023 Earnings Call, Feb 23, 2024

Sudhir Gandhi Leaves from Mega Lifesciences Public Company Limited as Regional Director of Sales and Marketing

January 05, 2014 at 08:03 pm EST

Mega Lifesciences Public Company Limited informed that Mr. Sudhir Gandhi, Regional Director of Sales and Marketing, has left the company effective from December 31, 2013. His contract with the company has expired.

Latest news about Mega Lifesciences

Mega Lifesciences Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 13	CI
Transcript : Mega Lifesciences Public Company Limited, 2023 Earnings Call, Feb 23, 2024	Feb. 22
Mega Lifesciences Public Company Limited Proposes Dividend for the Year Ended December 31, 2023, Payable on April 22, 2024	Feb. 22	CI
Mega Lifesciences Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 22	CI
Transcript : Mega Lifesciences Public Company Limited, Q3 2023 Earnings Call, Nov 14, 2023	Nov. 13
Mega Lifesciences Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Mega Lifesciences Public Company Limited Announces Cash Dividend for the Period from January 1, 2023to June 30, 2023, Payable on September 8, 2023	23-08-11	CI
Mega Lifesciences Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
Transcript : Mega Lifesciences Public Company Limited, Q1 2023 Earnings Call, May 15, 2023	23-05-14
Mega Lifesciences Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Mega Lifesciences Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-25	CI
Transcript : Mega Lifesciences Public Company Limited, 2022 Earnings Call, Feb 24, 2023	23-02-23
Transcript : Mega Lifesciences Public Company Limited, Q3 2022 Earnings Call, Nov 15, 2022	22-11-14
Mega Lifesciences Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Transcript : Mega Lifesciences Public Company Limited, Q2 2022 Earnings Call, Aug 15, 2022	22-08-14
Mega Lifesciences Public Company Limited Announces Cash Dividend for the Period from January 1, 2022 to June 30, 2022, Payable on September 9, 2022	22-08-11	CI
Mega Lifesciences Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
Transcript : Mega Lifesciences Public Company Limited, Q1 2022 Earnings Call, May 17, 2022	22-05-16
Mega Lifesciences Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-13	CI
Mega Lifesciences Public Company Limited Appoints Alan Kam to Be the Vice Chairman of the Board of Directors	22-04-05	CI
Mega Lifesciences Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-23	CI
Mega Lifesciences Public Company Limited Proposes Dividend for Year Ended December 31, 2021, Payable on April 22, 2022	22-02-23	CI
Mega Lifesciences Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
Mega Lifesciences Public Company Limited Announces Earnings Results for the Second Quarter Ended June 30, 2021	21-08-16	CI
Mega Lifesciences Public Company Limited Announces Cash Dividend for the Period from January 1, 2021 to June 30, 2021, Payable on September 14, 2021	21-08-16	CI

Chart Mega Lifesciences

Duration

Period

More charts

Company Profile

Mega Lifesciences Public Company Limited is engaged in manufacturing, marketing, selling and distributing quality pharmaceutical, nutraceutical products and Fast-Moving Consumer Goods (FMCG). Its segments include Maxxcare distribution business, Mega We Care branded products business, and original equipment manufacturer (OEM) business. The Maxxcare distribution business markets, sells and distributes various branded prescription pharmaceutical products, OTC and FMCG products. Its services include warehouse management, collections, including assuming the liability for bad debts, and value-added services. Its Mega We Care branded products business develops, manufactures, markets and sells its own brand of nutraceutical products, prescription pharmaceutical products and OTC products. Mega We Care branded products are sold in a total of 35 countries around the world. Its manufacturing facilities in Thailand and Australia accept various production orders from third-party customers.

Sector

Pharmaceuticals

Calendar

2024-05-29 - Shareholders Meeting - Q1 2024

More about the company

Income Statement Evolution

More financial data

Ratings for Mega Lifesciences

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

40.25 THB

Average target price

49.31 THB

Spread / Average Target

+22.52%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
MEGA LIFESCIENCES	0.00%	966M
ELI LILLY AND COMPANY	+37.78%	723B
NOVO NORDISK A/S	+31.28%	598B
JOHNSON & JOHNSON	-3.51%	364B
MERCK & CO., INC.	+19.94%	331B
ABBVIE INC.	+5.14%	288B
ASTRAZENECA PLC	+16.38%	244B
ROCHE HOLDING AG	-4.83%	208B
NOVARTIS AG	+10.07%	210B
AMGEN INC.	+9.32%	169B

Other Pharmaceuticals

Mega Lifesciences

Equities

MEGA

TH4984010009

Pharmaceuticals

Sudhir Gandhi Leaves from Mega Lifesciences Public Company Limited as Regional Director of Sales and Marketing

EPS Revisions